RESUMO
The striatum, known as the input nucleus of the basal ganglia, is extensively studied for its diverse behavioral roles. However, the relationship between its neuronal and vascular activity, vital for interpreting functional magnetic resonance imaging (fMRI) signals, has not received comprehensive examination within the striatum. Here, we demonstrate that optogenetic stimulation of dorsal striatal neurons or their afferents from various cortical and subcortical regions induces negative striatal fMRI responses in rats, manifesting as vasoconstriction. These responses occur even with heightened striatal neuronal activity, confirmed by electrophysiology and fiber-photometry. In parallel, midbrain dopaminergic neuron optogenetic modulation, coupled with electrochemical measurements, establishes a link between striatal vasodilation and dopamine release. Intriguingly, in vivo intra-striatal pharmacological manipulations during optogenetic stimulation highlight a critical role of opioidergic signaling in generating striatal vasoconstriction. This observation is substantiated by detecting striatal vasoconstriction in brain slices after synthetic opioid application. In humans, manipulations aimed at increasing striatal neuronal activity likewise elicit negative striatal fMRI responses. Our results emphasize the necessity of considering vasoactive neurotransmission alongside neuronal activity when interpreting fMRI signal.
Assuntos
Corpo Estriado , Imageamento por Ressonância Magnética , Humanos , Ratos , Animais , Imageamento por Ressonância Magnética/métodos , Corpo Estriado/fisiologia , Neostriado , Gânglios da Base , Neurônios DopaminérgicosRESUMO
Functional magnetic resonance imaging (fMRI) is widely used by researchers to noninvasively monitor brain-wide activity. The traditional assumption of a uniform relationship between neuronal and hemodynamic activity throughout the brain has been increasingly challenged. This relationship is now believed to be impacted by heterogeneously distributed cell types and neurochemical signaling. To date, most cell-type- and neurotransmitter-specific influences on hemodynamics have been examined within the cortex and hippocampus of rodent models, where glutamatergic signaling is prominent. However, neurochemical influences on hemodynamics are relatively unknown in largely GABAergic brain regions such as the rodent caudate putamen (CPu). Given the extensive contribution of CPu function and dysfunction to behavior, and the increasing focus on this region in fMRI studies, improved understanding of CPu hemodynamics could have broad impacts. Here we discuss existing findings on neurochemical contributions to hemodynamics as they may relate to the CPu with special consideration for how these contributions could originate from various cell types and circuits. We hope this review can help inform the direction of future studies as well as interpretation of fMRI findings in the CPu.
Assuntos
Putamen , Roedores , Animais , Putamen/diagnóstico por imagem , Putamen/patologia , Encéfalo/irrigação sanguínea , Imageamento por Ressonância Magnética/métodos , Hemodinâmica/fisiologiaRESUMO
The vascular contributions of neurotransmitters to the hemodynamic response are gaining more attention in neuroimaging studies, as many neurotransmitters are vasomodulatory. To date, well-established electrochemical techniques that detect neurotransmission in high magnetic field environments are limited. Here, we propose an experimental setting enabling simultaneous fast-scan cyclic voltammetry (FSCV) and blood oxygenation level-dependent functional magnetic imaging (BOLD fMRI) to measure both local tissue oxygen and dopamine responses, and global BOLD changes, respectively. By using MR-compatible materials and the proposed data acquisition schemes, FSCV detected physiological analyte concentrations with high temporal resolution and spatial specificity inside of a 9.4 T MRI bore. We found that tissue oxygen and BOLD correlate strongly, and brain regions that encode dopamine amplitude differences can be identified via modeling simultaneously acquired dopamine FSCV and BOLD fMRI time-courses. This technique provides complementary neurochemical and hemodynamic information and expands the scope of studying the influence of local neurotransmitter release over the entire brain.
Assuntos
Encéfalo/diagnóstico por imagem , Técnicas Eletroquímicas/métodos , Imageamento por Ressonância Magnética/métodos , Neurotransmissores/fisiologia , Oxigênio , Animais , Masculino , Neuroimagem , Ratos , Transmissão SinápticaRESUMO
Accurate removal of magnetic resonance imaging (MRI) signal outside the brain, a.k.a., skull stripping, is a key step in the brain image pre-processing pipelines. In rodents, this is mostly achieved by manually editing a brain mask, which is time-consuming and operator dependent. Automating this step is particularly challenging in rodents as compared to humans, because of differences in brain/scalp tissue geometry, image resolution with respect to brain-scalp distance, and tissue contrast around the skull. In this study, we proposed a deep-learning-based framework, U-Net, to automatically identify the rodent brain boundaries in MR images. The U-Net method is robust against inter-subject variability and eliminates operator dependence. To benchmark the efficiency of this method, we trained and validated our model using both in-house collected and publicly available datasets. In comparison to current state-of-the-art methods, our approach achieved superior averaged Dice similarity coefficient to ground truth T2-weighted rapid acquisition with relaxation enhancement and T2∗-weighted echo planar imaging data in both rats and mice (all p < 0.05), demonstrating robust performance of our approach across various MRI protocols.
RESUMO
Glutamate is ubiquitous throughout the brain and serves as the primary excitatory neurotransmitter. Neurons require energy to fire, and energetic substrates (i.e., O2, glucose) are renewed via cerebral blood flow (CBF) to maintain metabolic homeostasis. Magnetic resonance brain functionality studies rely on the assumption that CBF and neuronal activity are coupled consistently throughout the brain; however, the origin of neuronal activity does not always coincide with signals indicative of energy consumption (e.g., O2 decreases) at high spatial resolutions. Therefore, relationships between excitatory neurotransmission and energy use must be evaluated at higher resolutions. In this study, we showed that both endogenously released and exogenously ejected glutamate decrease local tissue O2 concentrations, but whether hyperemic O2 restoration followed depended on the stimulus method. Electrically stimulating the glutamatergic corticostriatal pathway evoked biphasic O2 responses at striatal terminals: first O2 decreased, then concentrations increased above baseline. Using iontophoresis to locally eject ionotropic glutamate receptor antagonists revealed that these receptors only influenced the O2 decrease. We compared electrical stimulation to iontophoretic glutamate stimulation, and measured concurrent single-unit activity and O2 to limit both stimulation and recordings to <50 µm radius from our sensor. Similarly, iontophoretic glutamate delivery elicited monophasic O2 decreases without subsequent increases.
Assuntos
Corpo Estriado/metabolismo , Neurônios/metabolismo , Oxigênio/metabolismo , Córtex Pré-Frontal/metabolismo , Receptores de Glutamato/metabolismo , Potenciais de Ação/fisiologia , Animais , Estimulação Elétrica , Eletrodos Implantados , Ácido Glutâmico/administração & dosagem , Ácido Glutâmico/metabolismo , Masculino , Ratos Sprague-DawleyRESUMO
BACKGROUND: Modern cerebral blood flow (CBF) detection favors the use of either optical technologies that are limited to cortical brain regions, or expensive magnetic resonance. Decades ago, inhalation gas clearance was the choice method of quantifying CBF, but this suffered from poor temporal resolution. Electrolytic H2 clearance (EHC) generates and collects gas in situ at an electrode pair, which improves temporal resolution, but the probe size has prohibited meaningful subcortical use. NEW METHOD: We microfabricated EHC electrodes to an order of magnitude smaller than those existing, on the scale of 100µm, to permit use deep within the brain. RESULTS: Novel EHC probes were fabricated. The devices offered exceptional signal-to-noise, achieved high collection efficiencies (40-50%) in vitro, and agreed with theoretical modeling. An in vitro chemical reaction model was used to confirm that our devices detected flow rates higher than those expected physiologically. Computational modeling that incorporated realistic noise levels demonstrated devices would be sensitive to physiological CBF rates. COMPARISON WITH EXISTING METHOD: The reduced size of our arrays makes them suitable for subcortical EHC measurements, as opposed to the larger, existing EHC electrodes that would cause substantial tissue damage. Our array can collect multiple CBF measurements per minute, and can thus resolve physiological changes occurring on a shorter timescale than existing gas clearance measurements. CONCLUSION: We present and characterize microfabricated EHC electrodes and an accompanying theoretical model to interpret acquired data. Microfabrication allows for the high-throughput production of reproducible devices that are capable of monitoring deep brain CBF with sub-minute resolution.